PAF-05

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePAF-05
Drug Alias Namealpha-enolase inhibiting antibody (RiboVax)PAF-05
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAlpha-enolase inhibitors
TargetsAlpha-enolase
Therapy Area/IndicationsCarcinoma, Pancreatic Ductal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRibovax Biotechnologies Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRibovax Biotechnologies Sa
Active IndicationsN/A
Inactive IndicationsCarcinoma, Pancreatic Ductal

Other Information

ATC CodeN/A
Related LinksN/A